Kontour(Xi’An) Medical Technology Co.Ltd(688314) : supplementary announcement on signing project agreement and foreign investment

Securities code: Kontour(Xi’An) Medical Technology Co.Ltd(688314) securities abbreviation: Kontour(Xi’An) Medical Technology Co.Ltd(688314) Announcement No.: 2022023 Kontour(Xi’An) Medical Technology Co.Ltd(688314)

Supplementary announcement on signing project agreement and foreign investment

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.

Kontour(Xi’An) Medical Technology Co.Ltd(688314) (hereinafter referred to as “the company”) in order to meet the increasing sterilization demand of its own product production and R & D, improve the company’s industrial supporting facilities and ensure product quality and safety, the company plans to sign an agreement on high-end medical device sterilization project with the Management Committee of Xi’an High Tech Industrial Development Zone, and use its own or self raised funds to invest in the construction of high-end medical device sterilization project in Xi’an high tech Zone.

The proposed signing agreement and foreign investment have been deliberated and adopted at the 23rd Meeting of the first board of directors of the company and posted on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on May 24, 2022 And the designated media disclosed the announcement of Kontour(Xi’An) Medical Technology Co.Ltd(688314) on signing project agreement and foreign investment (Announcement No.: 2022021).

In order for investors to further understand the foreign investment, the contents of the original announcement are supplemented as follows:

1、 Foreign investment scale and decision-making procedures

The proposed investment project is expected to cover a total area of 18 mu. According to the construction scale and future capacity planning, the company estimates that the total investment of the project is expected to be 133150 million yuan. The specific investment estimation is as follows:

Category amount

The cost of civil engineering is 60 million yuan to 67 million yuan

The equipment purchase and installation cost is 43 million yuan to 45 million yuan

Land transfer fee and other expenses: 15-18 million yuan

Basic reserve fund 5 million yuan

Initial working capital: 10-15 million yuan

According to the calculation of the company, the total amount of the proposed investment does not exceed 150 million yuan. The proposed investment is within the approval authority of the board of directors of the company and has been deliberated and approved at the 23rd Meeting of the first board of directors of the company, so it is not necessary to submit it to the general meeting of shareholders for deliberation.

2、 Necessity of project capacity planning and construction

The sterilization project of high-end medical devices to be constructed this time is the construction of ethylene oxide sterilization capacity. It is expected that after all the projects are completed and put into use, it can reach an average daily processing capacity of 500 cubic meters, an annual processing capacity of 120000 cubic meters and an annual processing capacity of about 5 million sets of medical devices.

At present, the annual sterilization demand of the company’s products is about 400000 sets. With the transformation from non sterile products to sterile products, the increase in the volume of some new products and products under research and the increase in the demand of products in the future, the sterilization demand of the company will double in the future. Up to now, there is no high-standard ethylene oxide sterilization center in Northwest China that meets the certification of foreign markets. The construction of this project will effectively alleviate the demand for product sterilization in the future, ensure product quality and safety, and meet the regulatory requirements of the company’s product globalization.

3、 Project land

The land to be transferred for the project is located in the Silk Road Software City area of Xi’an high tech Zone, with a total area of about 18 mu. The specific location and area of the land are subject to the contract for transfer of state-owned construction land use right signed.

4、 Construction cycle

After obtaining the land use right and relevant permits, the construction of the project is expected to be completed within 12 months to meet the completion conditions. The project is expected to be put into operation within 12 months from the completion date.

It is hereby announced.

Kontour(Xi’An) Medical Technology Co.Ltd(688314) board of directors may 24, 2022

- Advertisment -